![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1b.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study - UCL Discovery
![IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies](https://www.mdpi.com/ijms/ijms-24-02449/article_deploy/html/images/ijms-24-02449-g001.png)
IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies
![Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? | SpringerLink Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-019-02899-0/MediaObjects/345_2019_2899_Fig4_HTML.png)
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? | SpringerLink
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/cam1-min-768x431.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://www.mdpi.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g001.png)
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
![Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1532046415000805-fx1.jpg)
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/44717/deaths_crude_prostate-1.png)